Cocrystallization of racemic-compound-forming chiral molecules can result in conglomerate cocrystals or diastereomerically related cocrystals, which enable the application of chiral separation techniques such as preferential crystallization and classic resolution. Here, a systematic method to identify the types and phase diagrams of cocrystals formed by chiral target compounds and candidate coformers in a particular solvent system is presented, which allows the design of suitable chiral resolution processes. The method is based on saturation temperature measurements of specific solution compositions containing both enantiomers of chiral molecules and a coformer. This method is applied to analyze three different systems. For racemic phenylalanine (Phe) in water/ethanol mixtures one of the enantiomers selectively cocrystallizes with the opposite enantiomer of valine (Val), forming the more stable diastereomerically related cocrystal. The racemic compound ibuprofen crystallizes with the nonchiral coformer 1,2-bis(4-pyridyl)ethane (BPN) as racemic compound cocrystals. More interestingly, when it is combined with trans-1-(2-pyridyl)-2-(4-pyridyl)ethylene (BPE), the racemic compound ibuprofen cocrystallizes as a conglomerate, which in principle enables the application of preferential crystallization of this racemic compound. The systematic method shows the benefit of using pseudo-binary phase diagrams. Such pseudo-binary phase diagrams depict the saturation temperature on a very specific route through the quaternary phase diagram, allowing the identification of various cocrystal types as well as the corresponding cocrystallization conditions. The systematic method can be used to identify a suitable solid phase for chiral separation, and the obtained phase diagram information enables the performance of a crystallization-mediated chiral resolution process design. Such a guideline for a chiral resolution process design has never been reported for conglomerate cocrystal systems such as IBU:BPE, presented in this study.

@en

Crystallization-based chiral resolution techniques was born when Pasteur discovered the chirality of tartaric acid and manually separated its two enantiopure crystals by his tweezers. Ever since then, these techniques have been in constant development, mainly due to the needs from the pharmaceutical and food industries. In the past decades, techniques such as preferential crystallization have been studied and some of them have already been applied at pilot scale. Deracemization is of more recent date and is actually the process that stirs up attention in chiral resolution the last few years. These techniques draw more and more attention from both academic world and the industries owing to one common feature: the potential to recover the desired enantiomer with unrivaled high product purity in a single process step. @en

When applied to a pure component suspension in an apolar solvent, a strong inhomogeneous electric field induces particle movement, and the particles are collected at the surface of one of the two electrodes. This new phenomenon was used to separately isolate two organic crystalline compounds, phenazine and caffeine, from their suspension in 1,4-dioxane. First, crystals of both compounds were collected at different electrodes under the influence of an electric field. Subsequent cooling crystallization enabled the immobilization and growth of the particles on the electrodes, which were separately collected after the experiment with purities greater than 91%. This method can be further developed into a technique for crystal separation and recovery in complex multicomponent suspensions of industrial processes.@en

Salts of chiral molecules, which originally crystallize as racemic compounds, could form conglomerates. The utilization of such conglomerate salts, as intermediates for the deracemization of corresponding racemic compounds, expands the theoretical application range of Viedma Ripening by roughly 10-fold. In the present study, the use of temperature cycling on conglomerate forming salts as an alternative technique for Viedma Ripening was studied. The racemic compound Phenylalanine (Phe) was successfully deracemized via its conglomerate-forming salt with 2,5-xylenesulfonic acid (XSA) by continuous heating-cooling cycles applied to its suspension in glacial acetic acid, coupled with a solution racemization reaction. In addition, the dependence of the deracemization rate on the operational parameters was studied. Enhanced racemization reaction kinetics, either by a larger amount of free amino acid or by a higher concentration of catalyst, was shown to accelerate the deracemization process. It seems to indicate that a concentration difference between the two enantiomers, which could be diminished by a faster racemization rate, behaves as one of the major rate-limiting factors for the deracemization process. A larger mass fraction of solid dissolving and recrystallizing in the heating-cooling cycles, achieved by either a larger temperature swing or a smaller dry mass concentration, also leads to a faster deracemization. A change in cooling rate does not affect the deracemization rate significantly within the range tested, indicating a limited presence of secondary nucleation of the minor enantiomers. The results can be used as a preliminary foundation for process optimization as well as mechanisms investigation. The advantages and disadvantages of temperature cycling and Viedma Ripening, as deracemization methods in an industrial setting, are discussed.

@en